Patents by Inventor Sun Jun Yoon

Sun Jun Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150801
    Abstract: The present invention relates to a Corynebacterium glutamicum mutant strain having increased L-citrulline productivity, and a method of producing L-citrulline using the same. The Corynebacterium glutamicum mutant strain is capable of producing L-citrulline in high yield and high concentration while inhibiting the production of by-products, because the activity of the protein that is expressed by the NCgl2657 gene therein has been weakened or inactivated.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 9, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Moon Jeong KIM, Dong Seok LEE, Sun Jun YOON, Seok Hyun PARK, Joon Hyun PARK
  • Publication number: 20240026283
    Abstract: The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylornithine aminotransferase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-citrulline productivity in an increased yield compared to a parent strain.
    Type: Application
    Filed: October 4, 2022
    Publication date: January 25, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Mi RYU, Sun Jun YOON, In Pyo HONG, Seok Hyun PARK
  • Publication number: 20240026282
    Abstract: The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylglutamate kinase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-citrulline in an increased yield compared to a parent strain.
    Type: Application
    Filed: October 4, 2022
    Publication date: January 25, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Mi RYU, Sun Jun Yoon, In Pyo Hong, Seok Hyun Park